Multiple myeloma (MM) is an incurable blood cancer, leading to weakened immunity, bone damage, and other serious health ...
Braunstein, MD, PhD, FACP, and hematology/oncology fellow Olivia Main, MD, talk about their choices for a patient with ...
WIAT Birmingham on MSN3h
MMRF Multiple Myeloma Community Connect event to be held Nov. 14MMRF Multiple Myeloma Community Connect event to be held Nov. 14 ...
The department used its new system for determining whether a condition is service-connected to give affected veterans access ...
Multiple Myeloma (MM) is an incurable blood cancer, leading to weakened immunity, bone damage, and other serious health ...
Sanofi has taken a small step towards potentially overturning a recent rejection by NICE for NHS use of Sarclisa as a ...
Analyst Mitchell Kapoor from H.C. Wainwright reiterated a Buy rating on Legend Biotech (LEGN – Research Report) and keeping the price ...
Discontinuing development of istisociclib, a CDK9 inhibitor; benefit-risk profile in platinum-resistant high-grade serous ovarian cancer does ...
At a recent Community Case Forum, he discussed the use of CAR T-cell therapies for patients with multiple myeloma. He ...
Johnson & Johnson shows strong progress in oncology with Darzalex sales and regulatory filings, leading to a 'Buy' rating ...
Detailed price information for Legend Biotech Corp ADR (LEGN-Q) from The Globe and Mail including charting and trades.
We received FDA approval in the third line setting, making aema available to more patients living with multiple myeloma. And we've achieved a significant return to growth for a backline with third ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback